Source: International Congress 2018 – COPD around the world
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Malo De Molina Ruiz (Madrid , Spain), C. Esquinas (Barcelona, Spain), C. Martinez Rivera (Barcelona, Spain), E. Marquez Martin (Sevilla, Spain), E. Naval Sendra (Valencia , Spain), M. Valle Falcones (Madrid , Spain), E. Cabrera Cesar (Malaga, Spain), A. Boldova Loscertales (Zaragoza , Spain), J. Callejas (Albacete, Spain), M. Miravitlles (Barcelona, Spain). Characterization of patients with severe COPD. 754

Member's Comments

No comment yet.

Related content which might interest you: Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Quantification of severity of the acute exacerbation in hospitalized COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Predictors of severe COVID-19 in COPD Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 Care-continuity for COPD patients Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 COPD patients Source: Eur Respir Monogr 2021; 90: 154-164 Year: 2021 Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Anemia in COPD patients with an exacerbation Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Siccine acid effects in patients with exacerbation of severe COPD Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Occurrence and impact of bronchiectasis in patients with COPD Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations. Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Long-term effect of roflumilast on exacerbations in patients with severe to very severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006 Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019 Year: 2019 Prediction models for exacerbations in patients with COPD Source: Eur Respir Rev 2017; 26: 160061 Year: 2017 Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021